Sildenafil (Revatio) and tadalafil (Adcirca) are sometimes used to treat pulmonary hypertension. Sildenafil and its compounds have been found to improve exercise ability and reduce clinical PAH disease progression. Tadalafil, marketed under the name Adcirca, is used to treat patients with PAH because it can also improve exercising ability. Both medications are used to open the blood vessels in the lungs. As a result, they allow blood to flow through more easily.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?